Alnylam Pharmaceuticals (ALNY.MX) Q4 2016 Earnings

2NovConfirmed
Q1 2016
Q2 2016
Q3 2016
Q4 2016
-23.6
-21.86
-20.12
-18.39

Details

Expected EPS
-22.038728999999996
Actual EPS
-23.598993
Surprise EPS
-1.56
Surprise Percent
+7.08%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -23.598993 per share for Q4 2016.

0 Comments

Share your thoughts